Trade BIO-key International, Inc. - BKYI CFD

Trading Conditions
Spread0.0532
Long position overnight fee
Long position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
-0.026179 %
(-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


-0.026179%
Short position overnight fee
Short position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
0.003957 %
($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


0.003957%
Overnight fee time21:00 (UTC)
CurrencyUSD
Min traded quantity0.001
Margin20
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close1.5484
Open1.4784
1-Year Change130.64%
Day's Range1.4784 - 1.6984

BIO-key International, Inc. Company profile

About BIO-key International, Inc.

BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company's products include PortalGuard and PortalGuard identity-as-a-service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to customers. PortalGuard IDaaS offers flexible single sign-on and authentication options to meet users' security goals and deliver an optimized user experience. WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration application programming interfaces (APIs), allowing software developers to leverage its platform to securely embed biometric multi-factor authentication (MFA), into their own products.

Financial summary

BRIEF: For the nine months ended 30 September 2021, BIO-key International, Inc. revenues increased from $1.8M to $4.2M. Net loss applicable to common stockholders decreased 64% to $3M. Revenues reflect License fees increase from $605K to $2M, Hardware increase from $239K to $1.2M, Services increase of 6% to $985K. Lower net loss reflects Interest expense decrease of 100% to $18K (expense), Loss on extinguishment of debt decrease from $499K (expense) to

Equity composition

Common Stock $.0001 Par, 03/11, 170M auth., 78,155,413 issd. Insiders control 0.49%. IPO: 2/97,2,420,000 shares @ $3 by Tuschner & Company, Inc. 7/97, 2-for-1 stock split. Series A Convertible Preferred Stock $.0001 Par, 100K auth., 30,557 issd. Series D Convertible Preferred Stock $.0001 Par, 02/15, 1-for-2 reverse stock split.